Liver and intrahepatic bile ducts-nontumor
Reviewers: Komal Arora, M.D. (see Reviewers page)
Revised: 8 April 2012, last major update April 2012
Copyright: (c) 2004-2012, PathologyOutlines.com, Inc.
● Also called arteriohepatic dysplasia
● Autosomal dominant, due to mutations in Jagged1 gene on #20p, which encodes a ligand for Notch1 and plays a role in epithelial-mesenchymal interactions (Development 2010;137:4061)
● Normal liver, but no portal tract bile ducts; progressive loss, may occasionally regrow, may eventually involve large caliber bile ducts; also inflammation and non-uniform hepatic fibrosis
● Chronic cholestasis due to paucity of intrahepatic bile ducts, characteristic facies, vertebral arch anomalies, supravalvular pulmonic stenosis, posterior embryotoxon/anterior segment abnormalities, pigmentary retinopathy, and dysplastic kidneys (GeneReviews™ [Internet], retrieved 8 April 2012)
● May survive into adulthood, but increased risk of hepatic failure and hepatocellular carcinoma (Eur J Hum Genet 2012;20:251)
Liver: sequence of basic pathological lesion
Liver: CD10 expression
End of Liver and intrahepatic bile ducts-nontumor > Developmental anomalies/cysts > Alagille's syndrome
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).